# Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis

> **NCT00906399** · PHASE3 · COMPLETED · sponsor: **Biogen** · enrollment: 1516 (actual)

## Conditions studied

- Relapsing Multiple Sclerosis

## Interventions

- **DRUG:** BIIB017 (peginterferon beta-1a)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00906399
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2012-10
- **Final completion:** 2013-10
- **Target enrollment:** 1516 (ACTUAL)
- **Last updated:** 2014-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00906399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00906399, "Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00906399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*